H5N1 Testing Program Coming from CAP This Fall
While the current risk to humans of H5N1 remains low, CAP is launching a testing program to help labs better detect and subtype the virus.
Category: Emerging & Zoonotic Diseases
Emerging & Zoonotic Diseases
Latest
Emerging & Zoonotic Diseases
Latest
Alveo Technologies Partners with CDC to Advance Rapid Avian Flu Diagnostics
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
Emerging & Zoonotic Diseases
Latest
Lyme Disease ImmunoBlot Test Gets FDA Clearance
ID-FISH Technology's new test for the detection of IgG antibodies against Borrelia-causing Lyme disease has received FDA clearance.
New Biomarker Tech Differentiates Between Zika and Dengue Infections
A study detailed a new Zika virus-specific synthetic molecule that effectively distinguishes Zika from related dengue virus infections.
Read More
University Develops Urine Test for Early Lyme Disease Detection
George Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read More
Labcorp’s Mpox PCR Home Test Kit Granted FDA’s EUA
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read More
A New, Faster Point-of-Care Malaria Test Gets Developed
Researchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read More
Researchers Identify Hantavirus Through New Rapid Test to Curb Potential Outbreaks
A study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read More
How Disease Surveillance Will Help Spot Disease X
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read More
Black Individuals More Likely to Experience Inequities in Lyme Disease Diagnosis
A new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read More
Self-Sampling Proves Effective for Asymptomatic Mpox Diagnosis
A pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read More
Scientists Find Flaw in Malaria Diagnostics
Current diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read More
New Mpox Rapid Test is Adaptable for Other Diseases
A rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read More
Startup Gets $1 Million Grant to Build Infectious Disease Breathalyzer
Noze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read More
Cue Health’s Molecular Mpox Test Gets FDA EUA
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read More
Virax Biolabs Unveils Avian Influenza A Virus PCR Test
The test kit is for use in laboratory settings and can help healthcare professionals accurately identify an Avian Influenza A Virus infection.
Read More
Cepheid’s Mpox Test Gets Emergency Use Authorization
The FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read More
New Approach to Overcome Lyme Disease Diagnosis Challenges Gets Validation
A new study identified Raman spectroscopy as a promising diagnostic approach for Lyme disease, according to the Bay Area Lyme Foundation.
Read More